Parnax Lab

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE383L01019
  • NSEID:
  • BSEID: 506128
INR
118.50
-3.65 (-2.99%)
BSENSE

Feb 11

BSE+NSE Vol: 4.02 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Smruthi Organic
Parnax Lab
Panch.Organics
Lactose (India)
Kimia Bioscien.
Balaxi Pharma
Alpa Laboratorie
Sotac Pharma.
Pharmaids Pharma
Aptus Pharma
Astonea Labs

Why is Parnax Lab Ltd ?

1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 12.32%
2
Underperformed the market in the last 1 year
  • The stock has generated a return of 2.60% in the last 1 year, much lower than market (BSE500) returns of 13.00%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Parnax Lab for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Parnax Lab
2.6%
0.06
46.18%
Sensex
10.41%
0.90
11.52%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
17.11%
EBIT Growth (5y)
32.32%
Net Debt to Equity (avg)
0.77
Institutional Holding
0
ROE (avg)
12.32%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
12
Industry P/E
27
Price to Book Value
1.51
EV to EBIT
10.81
EV to EBITDA
7.68
EV to Capital Employed
1.29
EV to Sales
0.99
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
11.97%
ROE (Latest)
12.26%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company
OPERATING CF(Y)

Highest at Rs 32.30 Cr

DEBT-EQUITY RATIO(HY)

Lowest at 0.77 times

DEBTORS TURNOVER RATIO(HY)

Highest at 6.52 times

NET SALES(Q)

At Rs 62.60 cr has Grown at 31.1% (vs previous 4Q average

PBDIT(Q)

Highest at Rs 8.07 cr.

PBT LESS OI(Q)

Highest at Rs 4.57 cr.

PAT(Q)

Highest at Rs 3.63 cr.

EPS(Q)

Highest at Rs 3.16

-1What is not working for the Company
INTEREST(Q)

Highest at Rs 1.40 cr

Loading Valuation Snapshot...

Here's what is working for Parnax Lab

Operating Cash Flow - Annually
Highest at Rs 32.30 Cr
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (Rs Cr)

Net Sales - Quarterly
Highest at Rs 62.60 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 62.60 cr has Grown at 31.1% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 47.75 Cr
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 8.07 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 4.57 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 3.63 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 3.16
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Debt-Equity Ratio - Half Yearly
Lowest at 0.77 times
in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio- Half Yearly
Highest at 6.52 times
in the last five half yearly periods
MOJO Watch
Company has been able to settle its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Parnax Lab

Interest - Quarterly
Highest at Rs 1.40 cr
in the last five quarters and Increased by 14.75 % (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)